WINT 的背景情况，想了解这个跟 BNB 关系的进来看

$Windtree Therapeutics(WINT.US)

1. Research Background and Key Questions

The rumors you are concerned about can be broken down into four core judgments:

U.S.-listed company Windtree Therapeutics suddenly announced that it will allocate its treasury funds to BNB (Binance ecosystem token).
This plan stems from a $60 million initial subscription agreement signed with an investor named Build and Build Corp, with the possibility of an additional $140 million.
Windtree was originally a life sciences company, and this move is equivalent to a "MicroStrategy-like" shift in crypto asset strategy.
Key figures from Build and Build Corp previously founded the DeFi asset management firm Coral Capital.

This article verifies the above four points one by one based on public English information and marks the uncertainties. To avoid deviating from objective facts, the article does not involve trading indicators such as stock prices or valuations.

2. Information Sources and Verification Methods

Official disclosures: Windtree Therapeutics released the "BNB Crypto Treasury Strategy" announcement on its investor relations (IR) website and multiple press release platforms on 2025-07-16.
Mainstream financial media: CoinDesk, CoinTelegraph, Bloomberg Law, Finviz, etc., reported simultaneously.
Market information aggregation: AInvest, Microcaps, Investing.com, etc., reposted the news.
Investor background: Coral Capital's official website, Bloomberg's early reports, and the public resumes of Patrick Horsman and others.

3. Fact Verification

3.1 Windtree Therapeutics' Identity and Transformation

Dimension	Public Description	Verification Conclusion
Registered/Listed Location	Pennsylvania, USA • Nasdaq (ticker: WINT)	Consistent with SEC filings ✔️
Main Business	Drug development for respiratory diseases (life sciences)	Consistent with annual reports ✔️
Announcement Highlights	Signed a $60 million securities subscription agreement with Build and Build Corp, with proceeds to be used to build a treasury in BNB and potentially increase to a $200 million cap (including the additional $140 million).	Clearly disclosed in the announcement ✔️
Strategic Positioning	Aiming to become the "first Nasdaq-listed company to directly hold BNB," mirroring MicroStrategy's BTC reserve model	As stated in the announcement ✔️

Conclusion 1: Windtree has officially announced its involvement in the BNB reserve strategy, with the financial structure matching the numbers you provided.

3.2 Build and Build Corp Investment Terms

Detail	Announcement Disclosure	Verification Notes
Initial Investment	$60 million	Consistent with the question ✔️
Additional Amount	Up to an additional $140 million (total cap of $200 million)	Consistent with the question ✔️
Payment Form	Through private placement of Windtree convertible preferred shares and/or warrants	Stated in the announcement, subject to closing conditions ✔️
Closing Conditions	Including shareholder approval, regulatory filings, etc.	Completion risks remain ⚠️

Conclusion 2: The investment amount and phased terms are accurate, but whether the funds will be fully received depends on subsequent approvals and closing progress.

3.3 Build and Build Corp's Personnel Connection to Coral Capital

Individual	Public Title	Coral Capital Connection
Patrick Horsman, CFA	Co-founder of Build and Build Corp	Co-founder and managing partner of Coral Capital
Joshua Kruger	Partner at Build and Build Corp	Former head of trading at Coral DeFi
Johnathan Pasch	Partner at Build and Build Corp	Co-founded Kruger Pasch Capital with Kruger; Bloomberg reported as former Coral Capital executive

Conclusion 3: The three main members of Build and Build Corp have been identified by multiple media outlets as "former Coral Capital executives," confirming the personnel connection.

3.4 Other Pending Verification Items

Rumor Point	Current Evidence	Risk/Uncertainty
"Mystery Investor" Background	Official website and several articles claim support from Kraken, Galaxy, etc., but lack SEC official document verification	Need to track further disclosures on capital sources
Windtree's 30% Single-Day Stock Price Surge	Public market data shows significant fluctuations on the announcement day, but platforms vary in reporting, not necessarily exactly 30%	Per regulations, this report does not disclose real-time stock prices; refer to exchange data for confirmation

4. Comprehensive Assessment

Dimension	Credibility	Commentary
Announcement Authenticity	★★★★★	Released by Windtree IR, SEC 8-K, and multiple mainstream media outlets; highly credible.
Funding Realization Probability	★★★☆☆	Investment agreement signed but still requires shareholder approval and closing; Windtree's tight cash flow may complicate refinancing if closing fails.
Personnel Background and Coral Connection	★★★★☆	Multiple cross-references confirm personnel resumes; but Build and Build Corp's specific business model and compliance structure remain under-disclosed.
Strategic Sustainability	★★☆☆☆	Biotech company shifting to crypto asset reserves faces regulatory, financial, and governance challenges; monitor auditor opinions and Nasdaq compliance reviews.

5. Conclusions and Recommendations

The rumors have been confirmed by official announcements and mainstream financial media, with core financial and personnel information largely accurate.
The transaction is not yet complete and is subject to shareholder votes, funding, compliance audits, and other preconditions; continue monitoring Windtree's subsequent SEC reports and closing progress.
Build and Build Corp and its Coral Capital team have a background in crypto asset management, but their impact on corporate governance and financial transparency remains to be seen.
To further assess the comprehensive impact of Windtree's transformation on its biopharma business, financial stability, and regulatory compliance, consider auditor "going concern" opinions and Nasdaq filings for cautious analysis.

Disclaimer: The above content is based on public information and organized for timeliness, verifying facts only and not constituting any investment advice or judgment on asset price trends.